Development of the Swedish anticholinergic burden scale (Swe-ABS)

Development of the Swedish anticholinergic burden scale (Swe-ABS)

Abstract Background Drugs with anticholinergic properties are associated with cognitive adverse effects, especially in patients vulnerable to central muscarinic antagonism. A variety of drugs show weak, moderate or strong anticholinergic effects. Therefore, the cumulative anticholinergic burden shou...

Full description

Bibliographic Details
Main Authors: Tanja Rube, Astrid Ecorcheville, Elisabet Londos, Sara Modig, Per Johansson
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Geriatrics
Subjects:
Muscarinic cholinergic antagonists
Anticholinergic
Anticholinergic burden
Sweden
Anticholinergic adverse effects
Anticholinergic scales
Online Access:https://doi.org/10.1186/s12877-023-04225-1

Internet

https://doi.org/10.1186/s12877-023-04225-1

Similar Items